Previous history/findings | Died at 1 year (n = 39) | Alive at 1 year (n = 357) | p-value |
---|---|---|---|
Chronic stable angina, n (%) | 4 (10.3%) | 29 (8.1%) | 0.552 |
Myocardial infarction, n (%) | 26 (66.7%) | 221 (61.9%) | 0.560 |
Peripheral vascular disease, n (%) | 3 (7.7%) | 12 (3.4%) | 0.175 |
NYHA FC 1, n (%) | 4 (11.1%) | 74 (21.7%) | |
NYHA FC 2, n (%) | 18 (50.0%) | 209 (61.3%) | 0.012 |
NYHA FC 3, n (%) | 12 (33.3%) | 52 (15.2%) | |
NYHA FC 4, n (%) | 2 (5.6%) | 6 (1.8%) | |
Baseline HR (bpm), mean ± SD | 78.4 ± 17.1 | 77.1 ± 32.6 | 0.817 |
Target HR at 1 year (bpm), mean ± SD | 82.3 ± 16.3 | 73.3 ± 14 | 0.096 |
Baseline Systolic Blood Pressure, mmHg | 115.2 ± 23.2 | 124.4 ± 19.8 | 0.007 |
Baseline Diastolic Blood Pressure, mmHg | 66.9 ± 11.7 | 71.2 ± 12.7 | 0.044 |
Systolic Blood pressure at 1 year, mmHg | 111.8 ± 11.2 | 123.2 ± 19.2 | 0.094 |
Diastolic Blood pressure at 1 year, mmHg | 67 ± 10.4 | 70.4 ± 12 | 0.423 |
Electrocardiographic findings | |||
Sinus Rhythm, n (%) | 31 (83.8%) | 291 (87.7%) | 0.546 |
Atrial fibrillation n (%) | 5 (13.5%) | 28 (8.4%) | |
Rate (bpm), mean ± SD | 78.38 ± 15.65 | 76.03 ± 18.90 | 0.468 |
PR interval (ms), median (max, min) | 177 (104, 999) | 175 (0, 909) | 0.320 |
QRS complex duration (ms), mean ± SD | 114.35 ± 30.77 | 113.64 ± 27.51 | 0.883 |
Inferior leads (ІІ or ІІІ or aVF), n (%) | 14 (63.6%) | 88 (42.1%) | 0.053 |
Anterior leads (І or aVL), n (%) | 2 (9.1%) | 35 (16.7%) | 0.542 |
Lateral leads (V2-V5), n (%) | 14 (63.6%) | 150 (71.8%) | 0.424 |
Echocardiographic findings | |||
LVEF (%) by Simpson’s method, mean ± SD | 26.7 ± 7.6 | 30.2 ± 7.8 | 0.021 |
LVESV, mean ± SD ml | 130.96 ± 56.83 | 111.63 ± 50.98 | 0.046 |
LVEDV, mean ± SD ml | 185.8 ± 73.2 | 155.6 ± 64.2 | 0.014 |
LVEF (%) by Teicholz’s method, mean ± SD | 29.27 ± 10.70 | 32.01 ± 9.25 | 0.098 |
Mitral E wave velocity units, median (max, min) m/s | 89.7 (11.1, 250) | 64.1 (0.32, 167) | 0.040 |
Mitral A wave velocity, median (max, min) m/s | 61.6 (5.68, 124.2) | 66.1 (0.32, 149) | 0.753 |
Mitral deceleration time, mean ± SD ms | 142.9 ± 57.5 | 182.4 ± 85.7 | 0.041 |
RVSP mmHg, mean ± SD | 45.58 ± 18.45 | 40.64 ± 17.42 | 0.186 |
LV thrombus, n (%) | 3 (8.3%) | 15 (4.5%) | 0.402 |